Salient Pharmaceuticals' Angel - III Round

Salient Pharmaceuticals raised a round of funding on October 07, 2011. Investors include Central Texas Angel Network.

Salient Pharmaceuticals is a life science company developing a proprietary compound intended for use in treating severe diarrhea associated with chemotherapy, chronic conditions, infectious diseases a…

Articles about Salient Pharmaceuticals' Angel - III Round: